Improving access to cardiorenal protection in T2DM: implementing NICE guidance
Seminar
•
AstraZeneca
About the CPD course
Developed for primary care HCPs; this presentation supports HCPs in understanding the change in recent type 2 diabetes mellitus (T2DM) guidelines; how this incorporates cardiovascular and renal management; and how to select the most appropriate treatment for their patients. With practical advice and guidance from guideline bodies as well as expert speakers; this presentation supports HCPs to better manage people in their care with T2DM.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
